In this review, we discussed current SCD therapeutics and the specific stages of pathophysiology they target
Pharmacokinetics and safety of Iglarlixi in healthy chinese participants: Results of a phase 1 randomized study
However, they also raise important compliance concerns
Future research is necessary to scrutinize cellular and molecular mechanisms of action of AR in cancer cells and the tumour microenvironment, to develop selective modulators of AR activity, and to identify patients with non-prostatic cancer who might benefit from targeting this pathway
A key diagnostic challenge lies in distinguishing MPNSTs from benign nerve sheath tumors, which typically present as well-circumscribed lesions under 5 cm in diameter, often exhibiting characteristic features such as the target sign and fat split sign. MPNST must also be differentiated from other soft tissue sarcomas, such as alveolar soft part sarcoma and synovial sarcoma
For instance, Habanolide is a proprietary trade name for a specific aroma chemical
